Global Prostate Cancer Market 2016-2021: Competitive Landscape Analysis

According to the report "Prostate Cancer Market", published by Market Data Forecast, the global market is projected to reach USD 75.56 Billion by 2021, at a CAGR of 9.5% from 2016 to 2021.

View Report at http://www.marketdataforecast.com/market-reports/global-prostate-cancer-market-1616/

Prostate cancer is cancer which occurs in a man’s prostate. It is one of the most widespread types of cancer in men. Prostate cancer is a commercially profitable indication with a high amount of diagnosis incidences. New products inventions, partnership agreements, collaborations and acquisitions are some key strategies adopted by the players to get large market share in the forecast period.

Get free sample report at http://www.marketdataforecast.com/market-reports/global-prostate-cancer-market-1616/request-sample

Advancement in technology, personalized medicine, cost-effective treatment procedures are few other factors expected provide boost to global prostate cancer market. The market growth would turn around the novel breakthrough treatments accountable for reaping survival benefits. The survival benefit would be instrumental in leading the peak sales and market penetration of novel approved drugs.

Global Prostate Cancer Market is segmented by Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy and Region.

1. By Diagnostic Techniques:
•Digital Rectal Exam (DRE)
•Prostate Specific Antigen Test (PSA)

2. By Surgery:
•Radical Prostatectomy
•Orchidectomy
•Trans Urethral Resection (TUR)

3. By Radiation Therapy:
•External Beam Radiation Therapy
-3D Conformal Radiation Therapy
-Intensity Modulated Radiation Therapy
-Stereotactic Body Radiation Therapy
-Proton Beam Radiation Therapy

•Brachytherapy
-Permanent Brachytherapy
-Temporary Brachytherapy

4. By Chemotherapy:
•Docetaxel
•Etoposide
•Vinblastine
•Carboplatin
•Vinorelbine

5. By Geography:
•North America
•Europe
•Asia-Pacific
•Latin America
•Middle-East and Africa

Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc.

About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL-FREE)
abhishek@marketdataforecast.com

This release was published on openPR.